Filtros de búsqueda

Lista de obras de Carlos M Rodriguez-Ortigosa

A GAPDH-mediated trans-nitrosylation pathway is required for feedback inhibition of bile salt synthesis in rat liver

artículo científico publicado en 2014

A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury

artículo científico publicado en 2003

AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers

artículo científico publicado en 2011

Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I.

artículo científico publicado en 2002

Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger

scientific journal article

Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications.

artículo científico publicado en 2017

Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat.

artículo científico publicado en 2010

Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma

scientific article published on 04 January 2019

Effect of ursodeoxycholic acid on methionine adenosyltransferase activity and hepatic glutathione metabolism in rats

artículo científico publicado en 2002

Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in mice

artículo científico publicado en 2017

Enhanced actions of insulin-like growth factor-I and interferon-alpha co-administration in experimental cirrhosis.

artículo científico publicado en 2008

Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion

artículo científico publicado en 1997

Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.

artículo científico publicado en 2005

Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis.

artículo científico publicado en 2017

Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration

artículo científico publicado en 2017

Insulin-like growth factor 1 enhances bile-duct proliferation and fibrosis in Abcb4(-/-) mice.

artículo científico publicado en 2013

Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice.

artículo científico publicado en 2011

Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosis

artículo científico publicado en 2006

Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice.

artículo científico publicado en 2017

Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice

artículo científico publicado en 2010

Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition

artículo científico publicado en 2020

S-adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: a study with isolated and perfused rat liver

scientific article published on 01 August 1997

Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins

artículo científico publicado en 2019

Taurocholate-stimulated leukotriene C4 biosynthesis and leukotriene C4-stimulated choleresis in isolated rat liver

scientific article published on 01 June 1995

The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression.

artículo científico publicado en 2009

Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.

artículo científico publicado en 2013